LeadArtis is an Associated Company to the Immunotherapy Network

21-11-2011

The Immunotherapy Network IMMUNONET is a project approved under the Programme of Territorial Cooperation of the European Southwest Area (SUDOE-Interreg IV B). Bringing together leading international scientists, a stable team of cutting-edge research in Immunotherapy has been established in the southwestern Europe. The construction and remarkable work of the Network since 2009 has been possible thanks to the great efforts of its partner members and the increasing number of collaborators, and especially thanks to the support of the European Regional Development Fund. The project is structured in a virtual support center where research groups who cover practically all the areas of Immunotherapy share resources, equipment and information with universities, public administration and private initiatives. The ultimate goal of this Network is to develop and patent drugs of immunotherapeutic use for the treatment of infectious diseases, autoimmune diseases, cancer and initiate preclinical and clinical trials. The training of new researchers is also one of the main priorities of the Network. These young researchers see enriched their education thanks to the easy access to some of the best experts in Immunotherapy in the world. Also, the research of these groups is providing outstanding results evident in the scientific quality of their articles and studies that the groups present at conferences worldwide.

LeadArtis news image

Latest News

LeadArtis to present at the final Chemostart pitching initiative in recognition of its highly innovative R&D activity
31-01-2019
The Chemostart initiative (sponsored by the Chemo company) launched in 2018 as a call for...
LeadArtis project finalist of the Kaertor and J&J innovation award in recognition of its highly innovative R&D activity
08-11-2018
The Kærtor Foundation together with Janssen (a Johnson & Johnson company) launched in 2018...
Leadartis discloses the project: ATTACK-Cancer immunotherapy by bispecific antibodies that recruit T lymphocytes
11-12-2018

LeadArtis is pleased to announce its participation as coordinator of the ATTACK project (Cancer...